Next Generation News and Research

RSS

Wayne State researchers investigate PFAS impact on male fertility

A new grant from the National Institutes of Health (NIH) will help Wayne State University researchers explore potential connections between per- and polyfluoroalkyl substances (PFAS) exposure and adverse effects on male reproductive health.

17 Jun 2025

Small antibodies provide broad protection against SARS coronaviruses

Scientists have discovered a unique class of small antibodies that are strongly protective against a wide range of SARS coronaviruses, including SARS-CoV-1 and numerous early and recent SARS-CoV-2 variants.

14 Jun 2025

Rethinking brain imaging with light that travels through the head

For decades, scientists have used near-infrared light to study the brain in a noninvasive way. This optical technique, known as "fNIRS" (short for "functional near-infrared spectroscopy"), measures how light is absorbed by blood in the brain, to infer activity.

14 Jun 2025

How solvents influence drug delivery efficiency in MOFs

Even the best products won't meet expectations if they are packed poorly - packaging matters. The same goes for drug delivery.

13 Jun 2025

New CRISPR tool enables precise chemical modification of RNA in living cells

CRISPR-Cas13, a powerful RNA-targeting technology is gaining increasing attention as a next-generation gene therapy platform due to its precision and reduced side effects.

12 Jun 2025

How Fluidics is Powering Modern Healthcare and Medical Device Innovation

The future of fluidics in healthcare: Blake Webb shares trends in automation and microfluidics that are reshaping medical diagnostics and laboratory processes.

From Fluid Metering, Inc. 12 Jun 2025

Nanoplastics reshape gut microbiome, weakening gut defenses

Polystyrene nanoplastics impact gut health by modifying microbiota interactions via extracellular vesicles, raising concerns about environmental nanoplastics.

12 Jun 2025

Tufts researchers design new generation of weight loss medications

Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite their effectiveness, they have drawbacks.

11 Jun 2025

John Oldham redefines the landscape of personality disorders

In a comprehensive Genomic Press Interview published today in Brain Medicine, John M. Oldham, MD, MS, one of psychiatry's most influential architects of personality disorder theory, traces his remarkable journey from frontier medicine roots in Oklahoma to revolutionizing how mental health professionals understand and diagnose personality pathology.

11 Jun 2025

Mount Sinai receives NIH grant to study overdoses linked to synthetic opioids

The Icahn School of Medicine at Mount Sinai has been awarded a $3.8 million grant from the National Institute on Drug Abuse, a division of the National Institutes of Health, to study drug overdose cases linked to novel synthetic opioids.

10 Jun 2025

Research reveals the brain’s hidden shield against aging and neurodegeneration

In a compelling Genomic Press Interview published today in Brain Medicine, Sophia Shi, PhD, unveils her pioneering research that fundamentally changes our understanding of brain aging and opens revolutionary therapeutic pathways for Alzheimer's disease and related neurodegenerative conditions.

10 Jun 2025

Patient-derived xenograft models may become an indispensable tool in precision oncology

Cancer remains one of the most pressing global health challenges, with millions of new diagnoses each year. While precision medicine and targeted therapies have transformed treatment strategies, many patients still face drug resistance and disease recurrence.

10 Jun 2025

Shift Bioscience identifies novel single-gene target for safer cellular rejuvenation therapeutics

Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, today announced the publication of new research identifying a novel, single-gene target for cellular rejuvenation.

9 Jun 2025

New COVID variant NB.1.8.1 spreads across continents amid calls for vigilance

The Global Virus Network (GVN) is closely monitoring the emergence of a newly identified SARS-CoV-2 variant, NB.1.8.1, a sublineage of the Omicron family. This variant was first identified in January 2025 and has rapidly spread across Asia and into other regions, including parts of the United States.

6 Jun 2025

Pennington Biomedical’s Greaux Healthy initiative launches to improve child health in Louisiana

Pennington Biomedical Research Center publicly introduced its Greaux Healthy initiative, a public service initiative designed to help improve Louisiana kids' health at every age, during the weekly Red Stick Farmer's Market on Thursday.

6 Jun 2025

New Japanese database reveals how gut microbes and diet connect

Researchers have launched the NIBN Japan Microbiome Database, featuring over 2,000 gut microbiome profiles from healthy Japanese adults with extensive lifestyle and dietary metadata. This resource aims to accelerate microbiome-health research and enable precision medicine insights.

5 Jun 2025

Genetic study reveals why some children respond better to myopia lenses

Myopia, or nearsightedness, has reached epidemic levels worldwide, particularly in East and Southeast Asia.

5 Jun 2025

AI model diagnoses lung cancer using just a laptop

Imagine diagnosing cancer not with a supercomputer but on an ordinary laptop instead. Sounds like science fiction? Thanks to a revolutionary artificial intelligence (AI) model developed by Professor Kenji Suzuki and his research team from Institute of Science Tokyo (Science Tokyo), this far-fetched scenario is now a reality.

5 Jun 2025

FDA approves ENCELTO implant to preserve sight in people with macular telangiectasia type 2

For people diagnosed with macular telangiectasia type 2 (MacTel)-a rare and slowly progressing retinal disease-there have been no FDA-approved (or other) treatments to slow or stop vision loss.

4 Jun 2025

LabGenius Therapeutics appoints Dr. Angus Sinclair as Chief Scientific Officer

LabGenius Therapeutics (“LabGenius”) is a drug discovery company combining machine learning (ML) and high-throughput experimentation to optimize complex therapeutic antibodies, including those with multispecific designs.

4 Jun 2025